BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33016081)

  • 1. Anaphylaxis to intravenous paracetamol containing povidone. A case report and narrative review of excipient allergy related to anaesthesia.
    Preuss JF; Goddard CE; Clarke RC; Platt PR; Sadleir PH
    Anaesth Intensive Care; 2020 Sep; 48(5):404-408. PubMed ID: 33016081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylaxis following intravenous paracetamol: the problem is the solution.
    Jain SS; Green S; Rose M
    Anaesth Intensive Care; 2015 Nov; 43(6):779-81. PubMed ID: 26603804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetaminophen (paracetamol)-induced anaphylactic shock.
    Bachmeyer C; Vermeulen C; Habki R; Blay F; Leynadier F
    South Med J; 2002 Jul; 95(7):759-60. PubMed ID: 12144085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaphylaxis to polyvinylpyrrolidone in an analgesic preparation.
    Rönnau AC; Wulferink M; Gleichmann E; Unver E; Ruzicka T; Krutmann J; Grewe M
    Br J Dermatol; 2000 Nov; 143(5):1055-8. PubMed ID: 11069520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urticaria and anaphylaxis to povidone in a paracetamol preparation.
    Bergendorff O; Hansson C
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):573-4. PubMed ID: 17374012
    [No Abstract]   [Full Text] [Related]  

  • 6. Carboxymethylcellulose excipient allergy: a case report.
    Townsend K; Laffan J; Hayman G
    J Med Case Rep; 2021 Nov; 15(1):565. PubMed ID: 34819140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective anaphylaxis to paracetamol in a child.
    Couto M; Gaspar A; Morais-Almeida M
    Eur Ann Allergy Clin Immunol; 2012 Aug; 44(4):163-6. PubMed ID: 23092003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylactic shock following povidone.
    Gonzalo Garijo MA; Durán Quintana JA; Bobadilla González P; Máiquez Asuero P
    Ann Pharmacother; 1996 Jan; 30(1):37-40. PubMed ID: 8773164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaphylaxis to Excipients in Current Clinical Practice: Evaluation and Management.
    Bruusgaard-Mouritsen MA; Nasser S; Garvey LH; Krantz MS; Stone CA
    Immunol Allergy Clin North Am; 2022 May; 42(2):239-267. PubMed ID: 35469617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylaxis to povidone in a child.
    Pedrosa C; Costa H; Oliveira G; Romariz J; Praça F
    Pediatr Allergy Immunol; 2005 Jun; 16(4):361-2. PubMed ID: 15943602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaphylactic reaction due to paracetamol.
    Gowrinath K; Balachandran C
    J Indian Med Assoc; 2004 Apr; 102(4):223, 226. PubMed ID: 15473292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.
    Wolfson AR; Robinson LB; Li L; McMahon AE; Cogan AS; Fu X; Wickner P; Samarakoon U; Saff RR; Blumenthal KG; Banerji A
    J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3308-3320.e3. PubMed ID: 34166844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaphylactic reaction to povidone secondary to drug ingestion in a young child.
    Michavila-Gomez AV; Moreno-Palanques MA; Ferrer-Vazquez M; Ferriols-Leisart R; Bartolomé B
    Allergol Immunopathol (Madr); 2012; 40(4):259-61. PubMed ID: 21996435
    [No Abstract]   [Full Text] [Related]  

  • 14. AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergy.
    Ali SB; Perkins G; Ryoo D; Lee M; Tunbridge M; Yuson C; Smith W; Hissaria P; Le TT
    Allergy Asthma Clin Immunol; 2022 Mar; 18(1):22. PubMed ID: 35272714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines.
    Caballero ML; Quirce S
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):92-93. PubMed ID: 33433387
    [No Abstract]   [Full Text] [Related]  

  • 16. Paracetamol hypersensitivity: clinical features, mechanism and role of specific IgE.
    Rutkowski K; Nasser SM; Ewan PW
    Int Arch Allergy Immunol; 2012; 159(1):60-4. PubMed ID: 22555261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylaxis to Polyvinylpyrrolidone in Eye Drops Administered to an Adolescent.
    Liccioli G; Mori F; Barni S; Pucci N; Novembre E
    J Investig Allergol Clin Immunol; 2018 Aug; 28(4):263-265. PubMed ID: 30073960
    [No Abstract]   [Full Text] [Related]  

  • 18. Biologic excipients: Importance of clinical awareness of inactive ingredients.
    Ionova Y; Wilson L
    PLoS One; 2020; 15(6):e0235076. PubMed ID: 32584876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylaxis to paracetamol.
    Galindo PA; Borja J; Mur P; Feo F; Gómez E; García R
    Allergol Immunopathol (Madr); 1998; 26(4):199-200. PubMed ID: 9816409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaphylaxis Due to the Excipient Polysorbate 80.
    Palacios Castaño MI; Venturini Díaz M; Lobera Labairu T; González Mahave I; Del Pozo Gil MD; Blasco Sarramián A
    J Investig Allergol Clin Immunol; 2016; 26(6):394-396. PubMed ID: 27996954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.